Jeremy Barton

Dr. Barton has over 30 years of experience in all phases of oncology drug development in the pharmaceutical industry in Switzerland, UK and currently in the US. He is now working as a self-employed consultant, advising biotech companies on strategic oncology drug development. Dr. Barton’s most recent industry responsibilities in the US have included Chief Medical Officer roles at Biogen Idec, eFFECTOR Therapeutics, and Mirati Therapeutics. He was also head of early Oncology Development at Pfizer (San Diego) for 5 years overseeing the transition of all Oncology compounds from research through IND to proof-of-concept studies. After obtaining a Master’s Degree in Physiology from Oxford University and his MD degree at University College Hospital Medical School in London, he trained in Internal Medicine and Clinical Oncology in the United Kingdom and practiced for 11 years in the National Health Service. Dr. Barton is Board Certified in Internal Medicine and Clinical Oncology, a Member of the Royal College of Physicians, a Fellow of the Royal College of Radiologists (Clinical Oncology), and a Member of Faculty of Pharmaceutical Medicine.